Amcor plc (pro forma Amcor-Berry Global combination) AMCR
The Amcor-Berry merger creates a $36B packaging leader; executing $650M of conservatively-estimated synergies and a re-rate from 8x to 11x EBITDA delivers ~$16/share, a 50-70% upside.
Thesis
Ancora is pitching the pro forma Amcor-Berry Global combination, announced November 19, 2024, as a high-conviction long idea capping its three-year engagement with Berry. The all-stock $8.4B deal creates the largest global consumer-packaging company at $36B enterprise value, with $24B of revenue, $4.5B of pro forma EBITDA including $650M of identified procurement, G&A, operational, growth and financial synergies that Ancora views as conservative based on the Amcor-Bemis precedent. The combined entity trades at roughly 8.0x pro forma 2025 EBITDA versus Amcor's 11x five-year average and Berry's 7.7x, and is more than 40% accretive to adjusted EPS. Sensitivity analysis points to a $15-17 share price and 50-70% upside as synergies land and the multiple re-rates toward Amcor's historical premium.
SCQA
Amcor and Berry Global announced an $8.4B all-stock merger in November 2024 that creates the largest global consumer packaging company, with $24B of revenue and $4.5B of pro forma EBITDA capping Ancora's three-year engagement at Berry.
The market is valuing the pro forma business at only 8.0x EBITDA — a steep discount to Amcor's 11x five-year average — failing to credit the $650M of identified synergies, which Ancora views as conservative versus the Amcor-Bemis precedent.
Berry shareholders should support the deal to participate in combined upside, and investors should own pro forma Amcor as management executes $650M of procurement, G&A, growth and financial synergies and the multiple normalizes.
50% to 70% upside, with the share price rising from ~$10 today to ~$16 (and $15.86-$17.09 in the base case sensitivity) as $4.5B pro forma EBITDA is capitalized at an 11.0-11.5x multiple.
The three reasons
- 1
Amcor-Berry combination offers 50-70% upside as $650M synergies are realized
- 2
Pro forma 8.0x EBITDA is a steep discount to Amcor's 11x five-year average multiple
- 3
Combined company generates $24B revenue, $4.5B EBITDA and >$3B cash flow with 40% EPS accretion
Primary demands
- Berry shareholders should support the all-stock sale to Amcor to participate in long-term combined value creation
- Investors should buy combined Amcor as synergies are executed and valuation re-rates toward Amcor's historical premium multiple
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Precedents cited
- Amcor-Bemis transaction (synergy realization template)
- Ancora's prior Berry engagement (2021-2024) including HHNF/Magnera spinoff and CEO change
- Ancora's prior campaigns at Norfolk Southern, Mueller, and IAA/RB Global
Notable slides (6)
Notes
Bloomberg Activism Forum keynote-style investment idea pitch (Dec 10, 2024) by Ancora Alternatives' President James Chadwick. Filename prefix '2024-01' is misleading — actual cover date is December 10, 2024. Hybrid genre: a victory-lap recap of Ancora's three-year Berry Global engagement (CEO change, HHNF/Magnera spinoff, cooperation agreements) bridged into a fresh long-idea pitch on the pro forma Amcor-Berry combination. Classified as initial_thesis on AMCR rather than follow_up because the deck's primary purpose is presenting the combined entity as a new investment opportunity to a conference audience, not advancing a Berry campaign. Tone is constructive/analytical, not adversarial — no villain, no management contradictions; instead celebrates Berry's improved trajectory under Ancora's prior engagement. Strong use of timeline (p6), key-transaction-detail tiles (p8), synergy waterfall (p10), pro forma P&L (p11), peer multiple chart (p12), and sensitivity table (p14). Layout is clean institutional, with custom Ancora chevron branding and consistent blue/grey palette.